+
+

Related Products

  • Quaeris
    6 Ratings
    Visit Website
  • Stack AI
    20 Ratings
    Visit Website
  • Vertex AI
    726 Ratings
    Visit Website
  • RunPod
    152 Ratings
    Visit Website
  • Fraud.net
    56 Ratings
    Visit Website
  • Datasite Diligence Virtual Data Room
    469 Ratings
    Visit Website
  • BytePlus Recommend
    1 Rating
    Visit Website
  • Google AI Studio
    9 Ratings
    Visit Website
  • Veryon
    115 Ratings
    Visit Website
  • Valant Behavioral Health EHR
    321 Ratings
    Visit Website

About

We integrate clinical and experimental data using machine learning to navigate human disease biology and advance precision medicines. Our patent-pending Contingent AI™ understands relationships within the data to provide sophisticated insights. We address data bias by iterating on machine learning models based upon decisions made in the pre-processing and feature engineering stages. We leverage zebrafish, cellular and other phenotypic animal models to validate in silico predictions in vivo experiments and genetically modify them in vitro and in vivo, to improve translation. Using active learning and computer vision on validated models for cardiac, central nervous system and rare disorders, we rapidly incorporate new data into our machine learning models.

About

Plug’n play API to integrate with your diabetes management platform. Personalized therapeutic education. Better insights on BGL fluctuations. Real-time prediction to anticipate risks. Allow for more personalization and better regulation of the system. Handle complex living phases with rapid glucose changes. Telemedicine & retrospective analysis. Decision-support for patients. Hillo is currently working on the next versions of its AI technology, a therapeutic recommendation system to anticipate and prevent hypoglycemia and hyperglycemia, whose CE mark class IIB is planned for 2020, and the new generation of artificial pancreas(AP) for 2021, which will help overcome the main limitations of current AP systems thanks to the ultra-personalization provided by machine learning. The first self-learning artificial intelligence for predicting blood glucose levels to obtain CE mark as a medical device.

Platforms Supported

Windows
Mac
Linux
Cloud
On-Premises
iPhone
iPad
Android
Chromebook

Platforms Supported

Windows
Mac
Linux
Cloud
On-Premises
iPhone
iPad
Android
Chromebook

Audience

Health centers looking for a phenomics-driven drug discovery for better translation of human biology

Audience

Healthcare providers and clinical professionals looking for an AI solution to predict blood glucose levels

Support

Phone Support
24/7 Live Support
Online

Support

Phone Support
24/7 Live Support
Online

API

Offers API

API

Offers API

Screenshots and Videos

Screenshots and Videos

Pricing

No information available.
Free Version
Free Trial

Pricing

No information available.
Free Version
Free Trial

Reviews/Ratings

Overall 0.0 / 5
ease 0.0 / 5
features 0.0 / 5
design 0.0 / 5
support 0.0 / 5

This software hasn't been reviewed yet. Be the first to provide a review:

Review this Software

Reviews/Ratings

Overall 0.0 / 5
ease 0.0 / 5
features 0.0 / 5
design 0.0 / 5
support 0.0 / 5

This software hasn't been reviewed yet. Be the first to provide a review:

Review this Software

Training

Documentation
Webinars
Live Online
In Person

Training

Documentation
Webinars
Live Online
In Person

Company Information

BioSymetrics
United States
www.biosymetrics.com/platform

Company Information

Hillo
France
www.hillo.ai/

Alternatives

StarDrop

StarDrop

Optibrium

Alternatives

BIOiSIM

BIOiSIM

VERISIMLife
Altis Labs Nota

Altis Labs Nota

Altis Labs
AIDDISON

AIDDISON

Merck KGaA
CardioAI

CardioAI

XOresearch

Categories

Categories

Integrations

No info available.

Integrations

No info available.
Claim BioSymetrics and update features and information
Claim BioSymetrics and update features and information
Claim Hillo and update features and information
Claim Hillo and update features and information